the benefits of glp-1 drugs beyond obesity Genetics: How Genes Affect Appetite, Semaglutide, and Tirzepatide Response Photos by Nithin Kamath (@nithinkamath)
Description
Accessed September 24, 2021
The emergence of cagrilintide for weight loss and the cagrilintide-semaglutide combination adds further diversity to the available options
While demand for GLP-1 drugs appears to be accelerating, uncertainty around affordability, insurance coverage, and long-term access continues to shape whether interest translates into actual treatment
For RFS, the survival probabilities at five and 10 years were 95% and 90.9% with GLP-1RAs and 93.8% and 89.9% with SGLT2 inhibitors, respectively
What if I miss a dose
